OXFORD ASSET MANAGEMENT LLP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$13,000
-93.8%
15,239
-93.0%
0.00%
-66.7%
Q4 2019$209,000
-30.8%
217,568
-25.7%
0.01%
-14.3%
Q3 2019$302,000
-51.5%
292,943
-15.3%
0.01%
-46.2%
Q2 2019$623,000
-18.2%
345,879
-14.7%
0.01%
-23.5%
Q1 2019$762,000
+29.8%
405,583
-18.4%
0.02%
+13.3%
Q4 2018$587,000
-56.0%
497,198
-2.4%
0.02%
-46.4%
Q3 2018$1,333,000
+187.9%
509,390
+48.4%
0.03%
+75.0%
Q4 2016$463,000
+41.6%
343,172
+63.5%
0.02%
+60.0%
Q3 2016$327,000
-68.1%
209,862
-72.8%
0.01%
-70.6%
Q2 2016$1,026,000
-74.9%
771,506
-0.6%
0.03%
-70.9%
Q1 2016$4,091,000
-45.8%
776,236
-19.4%
0.12%
-34.3%
Q4 2015$7,551,000
+6957.0%
962,607
+7496.3%
0.18%
+5833.3%
Q3 2015$107,000
-98.6%
12,672
-98.2%
0.00%
-98.6%
Q2 2015$7,779,000
+91.2%
710,398
+144.1%
0.21%
+102.9%
Q1 2015$4,069,000
-59.0%
291,066
-50.0%
0.10%
-52.3%
Q4 2014$9,931,000
+87.2%
582,089
+91.5%
0.22%
+84.7%
Q3 2013$5,304,000
-59.8%
303,934
-62.5%
0.12%
-66.9%
Q2 2013$13,184,000811,3310.36%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders